NasdaqGS - Nasdaq Real Time Price USD

LifeStance Health Group, Inc. (LFST)

6.11 0.00 (0.00%)
As of 9:31 AM EDT. Market Open.
Loading Chart for LFST
DELL
  • Previous Close 6.11
  • Open 6.11
  • Bid 5.99 x 200
  • Ask 6.16 x 100
  • Day's Range 6.11 - 6.20
  • 52 Week Range 4.74 - 9.59
  • Volume 15,437
  • Avg. Volume 1,367,109
  • Market Cap (intraday) 2.326B
  • Beta (5Y Monthly) 1.34
  • PE Ratio (TTM) --
  • EPS (TTM) -0.51
  • Earnings Date May 9, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 8.79

LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates an outpatient mental health platform, as well as offers patient care virtually through its online delivery platform or in-person at its centers. LifeStance Health Group, Inc. was founded in 2017 and is headquartered in Scottsdale, Arizona.

lifestance.com

9,325

Full Time Employees

December 31

Fiscal Year Ends

Recent News: LFST

Performance Overview: LFST

Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

LFST
21.97%
S&P 500
6.47%

1-Year Return

LFST
23.91%
S&P 500
22.86%

3-Year Return

LFST
--
S&P 500
19.80%

5-Year Return

LFST
--
S&P 500
19.80%

Compare To: LFST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: LFST

Valuation Measures

Annual
As of 4/24/2024
  • Market Cap

    2.33B

  • Enterprise Value

    2.76B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.13

  • Price/Book (mrq)

    1.63

  • Enterprise Value/Revenue

    2.61

  • Enterprise Value/EBITDA

    -26.26

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -17.64%

  • Return on Assets (ttm)

    -5.18%

  • Return on Equity (ttm)

    -12.64%

  • Revenue (ttm)

    1.06B

  • Net Income Avi to Common (ttm)

    -186.26M

  • Diluted EPS (ttm)

    -0.51

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    78.82M

  • Total Debt/Equity (mrq)

    35.76%

  • Levered Free Cash Flow (ttm)

    13.57M

Research Analysis: LFST

Analyst Price Targets

8.00
8.79 Average
6.11 Current
10.00 High
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Company Insights: LFST

Fair Value

6.11 Current
 

Dividend Score

0 Low
LFST
Sector Avg.
100 High
 

Hiring Score

0 Low
LFST
Sector Avg.
100 High
 

Insider Sentiment Score

0 Low
LFST
Sector Avg.
100 High
 

People Also Watch